SCIENTIFIC HUB

Follow the evidence.

106.962 articles found

Open access

A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.

Merchant KM, Cedarbaum JM, Brundin P, Dave KD, Eberling J, Espay AJ, Hutten SJ, Javidnia M, Luthman J, Maetzler W, Menalled L, Reimer AN, Stoessl AJ, Weiner DM, The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group.

J Parkinsons Dis · 2019-01-01

DOI: 10.3233/jpd-181471PMID: 30400107

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

ERRATUM Mechanism of Nanotization-Mediated Improvement in the Efficacy of Caffeine Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism (Journal of Biomedical Nanotechnology, Vol. 11(12), pp. 2211-2222 (2015)).

Singhal NK, Agarwal S, Bhatnagar P, Tiwari MN, Tiwari SK, Srivastava G, Kumar P, Seth B, Patel DK, Chaturvedi RK, Singh MP, Gupta KC.

J Biomed Nanotechnol · 2019-01-01

DOI: 10.1166/jbn.2019.2662PMID: 30480528

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.